Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

B. Scheiner, D. Roessler, S. Phen, M. Lim, K. Pomej, T. Pressiani, A. Cammarota, T. W. Frundt, Felden J. von, K. Schulze, V. Himmelsbach, F. Finkelmeier, A. Deibel, A. R. Siebenhuner, K. Shmanko, P. Radu, B. Schwacha-Eipper, M. P. Ebert, A. Teufel, A. DjananiF. Hucke, L. Balcar, A. B. Philipp, D. Hsiehchen, M. Venerito, F. Sinner, M. Trauner, A. D'Alessio, C. A. M. Fulgenzi, David James PINATO, M. Peck-Radosavljevic, J. -F. Dufour, A. Weinmann, A. E. Kremer, A. G. Singal, Toni E. N. De, L. Rimassa, M. Pinter

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science